MENU

SGMO Sangamo Therapeutics Forecast, Technical & Fundamental Analysis

a developer of transcription factors in the regulation of genes

Industry Biotechnology
SGMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
SGMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SGMO is expected to report earnings to fall 293.75% to -7 cents per share on February 19

Sangamo Therapeutics SGMO Stock Earnings Reports
Q4'24
Est.
$-0.08
Q3'24
Beat
by $0.06
Q2'24
Missed
by $0.03
Q1'24
Missed
by $0.08
Q4'23
Missed
by $0.08
The last earnings report on November 12 showed earnings per share of 3 cents, beating the estimate of -1 cents. With 9.98M shares outstanding, the current market capitalization sits at 487.19M.
A.I. Advisor
published General Information

General Information

a developer of transcription factors in the regulation of genes

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
501 Canal Boulevard
Phone
+1 510 970-6000
Employees
405
Web
https://www.sangamo.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

SGMO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SGMO has been loosely correlated with XNCR. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if SGMO jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGMO
1D Price
Change %
SGMO100%
+6.62%
XNCR - SGMO
38%
Loosely correlated
+2.12%
ZYME - SGMO
36%
Loosely correlated
-2.90%
GLUE - SGMO
32%
Poorly correlated
-0.13%
CRSP - SGMO
32%
Poorly correlated
+0.88%
PGEN - SGMO
30%
Poorly correlated
+2.46%
More